glaucoma

Value-Based Payment program presents potential ramificationsOphthalmologists need to prepare their practices for the Value-Based Payment (VBP) program for Medicare services. VBP is a strategy to promote quality and value of health care services, with providers being paid based on value-of-care-delivered rather than volume. Regardless of the perspectives, the fact remains that reimbursement can increase or decrease substantially with the VBP program.
7 common mistakes in managing uveitic glaucomaGlaucoma is a common complication of uveitis, occurring in about 20% of affected eyes and arising through several different mechanisms. Here are seven common mistakes clinicians make in evaluating and managing elevated IOP in eyes with uveitis.
New approaches and technologies offer hope in vision restorationNew agents and devices offer promise to control IOP and slow, perhaps even stop, the advancing vision loss that is common in glaucoma. Research and development to restore vision is starting to show significant results in preclinical models and early stage clinical trials.
Addressing ocular surface toxicity in glaucoma patientsDry eye is common in patients with glaucoma and often presumed to be related to the preservative in IOP-lowering medications. Considering alternate causes should also be weighed, in addition to a variety of management techniques.
New technology helps IOP measurementNot long ago, a colleague asked me if I performed Goldmann tonometry on all of my glaucoma patients. Without hesitation I said, “No.” When asked why not, I simply answered that not all of my patients are physically able to have the test performed on them.
Flying Eye Hospital aims to prevent blindness worldwide
Flying Eye Hospital aims to prevent blindness worldwideA unique, third-generation Flying Eye Hospital is giving wings to Orbis' mission to prevent blindness worldwide. The hospital is the world’s only mobile ophthalmic teaching hospital located on an MD-10 aircraft, and is the byproduct of six years of work by experts in aviation and hospital engineering.
6 things you need to know: Genetic markers for glaucoma identifiedThe latest news and research you need to know about this week.
Novel dual agonist leads to notable IOP loweringThe drug ONO-9054 led to a greater reduction in IOP and a longer duration of reduction in a small clinical trial compared with latanoprost.
Lab RGCs expanding opportunities for glaucoma researchRetinal ganglion cells can be generated from patient-specific, induced pluripotent stem cells and serve as an in vitro model for pharmacologic screening and pathophysiology studies.
What astronauts can teach us about glaucoma
What astronauts can teach us about glaucomaNASA’s Vision Impairment and Intracranial Pressure (VIIP) project was started after NASA realized many astronauts return from space with vision problems, and these problems may last for years after mission completion.